Pharmaceutical Benefit-sharing

Pharmaceutical Benefit-Sharing is a benefit-sharing agreement mechanism that belongs to the broader category of equitable access frameworks, specifically characterized by the systematic return of medical, financial, or technological benefits derived from pharmaceutical research and development to the populations or jurisdictions contributing to the discovery and production processes.

47

Publications

2.1K

Citations

119

Authors

64

Institutions

Publications per year

2017–2026

9

Authors

119

  1. GS
    Gregory S. Zaric

    Western University, Canada

    4 publications · 91 citations

    4

    h-index

  2. KA
    Kevin A. Schulman

    Duke University, United States

    2 publications · 229 citations

    2

    h-index

  3. RM
    Reza Mahjoub

    Western University, Canada

    2 publications · 37 citations

    2

    h-index

  4. FØ
    Fredrik Ødegaard

    Western University, Canada

    2 publications · 37 citations

    2

    h-index

  5. RP
    Richard Parsons

    Curtin University, Australia

    1 publications · 10 citations

    1

    h-index

1–5 of 119

Venues

  1. Value in Health

    4 publications · 76 citations

    4

    h-index

  2. The Medical Journal of Australia

    MJA · 4 publications · 357 citations

    4

    h-index

  3. BMJ

    3 publications · 125 citations

    3

    h-index

  4. Science

    2 publications · 92 citations

    2

    h-index

  5. Australian Health Review

    2 publications · 35 citations

    2

    h-index

1–5